Hager Biosciences is a privately-owned biopharm-aceutical company established by experienced medicinal chemists to provide pre-clinical therapeutic leads and candidates through operationally agile & effective drug discovery chemistry platforms for the pharmaceutical and biotech industries.


Dr. Selena Bartlett, BPharm., Ph.D., Director of the Medications Development Group, Ernest Gallo Clinic & Research Center, University of California San Francisco, CA, USA 

Kelly Chibale, Ph.D., Professor of Chemistry & Director of the Drug Discovery & Development Centre (H3-D), University of Cape Town, Cape Town, South Africa

Hager Biosciences is in the final stages of completing its SAB core membership team

  • Hager Biosciences
  • ||
  • 116 Research Drive, Suite 265
  • ||
  • Bethlehem, PA 18015, USA
  • ||
  • Call: 610-849-5075
  • ||
  • Fax: 610-849-5001
  • ||
  • Email: info@hagerbio.com
  • Copyright © Hager Biosciences, LLC.